Plant Summary
TCMBank_ID: | TCMBANKHE007446 |
ID: | TCMBANKHE007446 |
植物拉丁名: |
|
功能与主治: | Treatment of: 1. Hemorrhages due to external injuries. Dragon's blood (Xuejie) can be taken alone for external use, or it can be combined with Cattail pollen (Puhuang). 2. Chronic ulcers. Dragon's blood (Xuejie) is used with Frankincense (Ruxiang) and Myrrh (Moyao) for external use. 3. Swelling and pain due to blood stagnation caused by external injuries. Dragon's blood (Xuejie) is used with Frankincense (Ruxiang) and Myrrh (Moyao) in the formula Qili San./1. Hemostatic.2. Inhibiting the growth of various kinds of dermatomyces. |
药用植物名: | 血竭 |
药用部位: | Daemonorops draco Bl. |
药味: | Mild; Sweet; Salty |
经络: | Liver; Heart |
临床特征: | 1. Hemostatic.2. Inhibiting the growth of various kinds of dermatomyces. |
治疗类型: | 活血化淤 |
TCM_ID_id: | 1569 |
TCMSP_id: | 174 |
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN005934 | (2s)-5-methoxy-6-methyl-flavan-7-ol | (2s)-5-methoxy-6-methylflavan-7-ol | C17H18O3 | 270.32 g/mol | CC1=C(C2=C(C=C1O)OC(CC2)C3=CC=CC=C3)OC |
TCMBANKIN008309 | dracoresene | ||||
TCMBANKIN012086 | dracoalban | ||||
TCMBANKIN024847 | phlobaphen | ||||
TCMBANKIN026883 | dracorhodin | C17H14O3 | 266.29 g/mol | CC1=C(C2=CC=C(OC2=CC1=O)C3=CC=CC=C3)OC | |
TCMBANKIN032364 | dracoresinotannol | ||||
TCMBANKIN033257 | (2s)-5-methoxy-flavan-7-ol | (2s)-5-methoxy flavan-7-ol | C16H16O3 | 256.3 g/mol | COC1=CC(=CC2=C1CCC(O2)C3=CC=CC=C3)O |
TCMBANKIN034254 | oleanonic aldehyde | C30H46O2 | 438.7 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)C)C=O)C | |
TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
TCMBANKIN037880 | dracorubin | C32H24O5 | 488.5 g/mol | CC1=C2C3=C(C=C(OC3=CC1=O)C4=CC=CC=C4)C5=C6C(=C(C=C5O2)OC)CCC(O6)C7=CC=CC=C7 | |
TCMBANKIN038100 | nordracorhodin | C16H12O3 | 252.26 g/mol | COC1=CC(=O)C=C2C1=CC=C(O2)C3=CC=CC=C3 | |
TCMBANKIN041161 | abietic acid | C20H30O2 | 302.5 g/mol | CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)O)C | |
TCMBANKIN043557 | 4'-Dihydroxywogonin | C16H12O7 | 316.262 | c1(O[H])c([H])c(O[H])c(C(=O)C([H])=C(c2c([H])c(O[H])c(O[H])c([H])c2[H])O3)c3c1OC([H])([H])[H] | |
TCMBANKIN043644 | pimaric acid | C21H32O2 | 316 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]2(C([H])([H])[H])C(=C([H])[C@@](C([H])=C([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])C([H])([H])C3([H])[H])[C@]3([H])[C@@](C(O[H])=O)(C([H])([H])[H])C 1([H])[H] | |
TCMBANKIN048493 | Nordracorubin | 474.5 g/mol | |||
TCMBANKIN059643 | sandaracopimaric acid | C20H30O2 | 302.5 g/mol | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)C=C | |
TCMBANKIN059645 | isopimaric acid | C20H30O2 | 302.5 g/mol | CC1(CCC2C(=CCC3C2(CCCC3(C)C(=O)O)C)C1)C=C | |
TCMBANKIN060547 | ursolic aldehyde | C30H48O2 | 440.7 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C=O |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
---|